AstraZeneca secures approval to market cancer therapy Enhertu in India for new indication
Drug firm AstraZeneca Pharma India Limited on Friday (October 3) said it has received approval from the Central Drugs Standard Control Organisation (CDSCO), Directorate...
SEBI clears IHH Healthcare’s long-stalled 26.1% Fortis open offer after seven years
The long-delayed open offer by IHH Healthcare Berhad for a 26.1% stake in Fortis Healthcare has finally received the nod from India’s capital market...
Household savings in equities and mutual funds jump nearly three-fold in three years
As of March 2025, equities and mutual funds together accounted for 15.2% of household savings—amounting to ₹5.4 lakh crore—up sharply from about ₹2 lakh...
MOIL posts record September output, Q2 production up 10.3%
India’s state-owned manganese producer MOIL Ltd on Friday reported its best-ever September production at 1.52 lakh tonnes, up 3.8% from a year earlier, supported...
Lupin launches blood sugar control injection in US
Mumbai-based pharma company Lupin Ltd has launched Liraglutide injection to help control blood sugar in the United States.The injection, available in an 18 mg/3...
